Search

Author/Creator Pang, Tuling

1. A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy. Issue 1 (1st January 2020)

Authors:
Miao, Xiaoniu; Luo, Yi; Huang, Xi; Lee, Suki M. Y.; Yuan, Zhijun; Tang, Yongzhou; Chen, Liandi; Wang, Chao; Wu, Fan; Xu, Yifeng; Jiang, Wenchao; Gao, Wei; Song, Xuedong; Yan, Yao; Pang, Tuling; Chen, Cheng; Zou, Yuefeng; Fu, Weihui; Wan, Liping; Gilbert-Jaramillo, Javier
Journal:
MAbs
Issue:
Volume 12:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Generation of a safe and efficacious llama single-domain antibody fragment (vHH) targeting the membrane-proximal region of 4-1BB for engineering therapeutic bispecific antibodies for cancer. Issue 6 (25th June 2021)

Authors:
Zhai, Tianhang; Wang, Chao; Xu, Yifeng; Huang, Weifeng; Yuan, Zhijun; Wang, Tao; Dai, Shuang; Peng, Shaogang; Pang, Tuling; Jiang, Wenchao; Huang, Yuhua; Zou, Yuefeng; Xu, Yingda; Sun, Joanne; Gong, Xinjiang; Zhang, Jinping; Tsun, Andy; Li, Bin; Miao, Xiaoniu
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 6(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search